GAIN THERAPEUTICS INC

Ticker: GANX CUSIP: 36269B105 Class: COM

NewEdge Advisors, LLC's Holding History (CIK: 0001633516)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 10,600 Value ($000) $34 Avg Close $2.67 Range $1.66 - $4.34
Q3 2025
Shares 10,600 Value ($000) $19 Avg Close $1.69 Range $1.41 - $2.12
Q2 2025
Shares 10,600 Value ($000) $19 Avg Close $1.85 Range $1.48 - $2.27
Q1 2025
Shares 10,600 Value ($000) $20 Avg Close $2.22 Range $1.54 - $2.81
Q1 2024
Shares 225 Value ($000) $1 Avg Close $4.15 Range $3.17 - $5.33
Q3 2023
Shares 11,050 Value ($000) $36 Avg Close $3.79 Range $3.03 - $4.78
Q2 2023
Shares 11,050 Value ($000) $50 Avg Close $4.88 Range $4.25 - $6.19
Q1 2023
Shares 10,500 Value ($000) $54 Avg Close $4.09 Range $3.15 - $5.25